Spirometry Market Overview:
Within the spirometry market, breathing spirometers are essential devices used to assess lung function and respiratory health in various clinical settings. A breathing spirometer measures the volume of air inspired and expired by the lungs, providing valuable information about lung capacity, respiratory muscle strength, and breathing patterns. These tests are commonly used in preoperative evaluations, pulmonary rehabilitation programs, and intensive care units to monitor respiratory function and optimize patient care. With user-friendly designs and digital interfaces, breathing spirometers enable patients to perform lung function tests with ease and accuracy, facilitating early detection of respiratory abnormalities and guiding personalized treatment plans. As healthcare providers continue to prioritize respiratory health and disease prevention, the demand for breathing spirometers is expected to drive innovation and growth in the spirometry market, improving patient outcomes and quality of life.
Spirometry Market insights report has valued the industry size at USD 1.93 billion in 2022 and is projected to grow from USD 0.6 Billion in 2023 to USD 1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9% during the forecast period (2023 - 2030).
Market Drivers and Restraints:
Rise in prevalence of lung disorders due to increasing pollution, changing lifestyle, tobacco smoking addiction and others are inducing high demand for improved spirometry tests in the global market, which in turn is propelling the growth of the global spirometry market. Introduction of advanced medical devices that are compact and easy-to-use and increased healthcare expenditure are some other important factors that are fueling the growth of the global spirometry market. However, lack of awareness and low penetration of technologically advanced healthcare solutions are some of the major factors that are likely to restrain the growth of the global spirometry market during the assessment period.
Market Segmentation:
The global spirometry market has been segmented on the basis of product, technology, application, and end-user. Based on product, the spirometry market has been segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. Based on technology, the spirometry market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry. The flow measurement spirometry technology segment is sub-segmented into pneumotachograph system and mass flow meter. Based on application, the spirometry market has been segmented into diagnostic and treatment monitoring. The diagnostic segment has been sub-segmented into COPD, asthma, and interstitial pulmonary fibrosis. Based on end-users, the spirometry market has been segmented into research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Analysis:
Geographically, the global human growth hormone market has been segmented into the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas accounted for the major share in the global spirometry market owing to the easy adoption of technically advanced medical devices, high prevalence of pulmonary disorders due to pollution and changing lifestyle and high healthcare expenditure by the population in this region. The Europe region is forecasted to expand at a significant growth rate in the global spirometry market during the assessment period owing to the high demand for advanced spirometers in the well-developed healthcare sector and proliferation of asthma cases in this region. The spirometry market in the Asia Pacific region is anticipated to expand at a notable growth rate in the global market owing to the increasing awareness regarding lung disorders and their adverse effects on health, increasing adoption of advanced healthcare solutions and high prevalence of lung disorders in this region. Improvement in healthcare infrastructure and enhanced healthcare budget are driving the spirometry market in the Middle East and Africa region.
Key Players:
The leading players profiled by MRFR's Spirometry Market outlook report, that are operating in the global spirometry market are Carefusion Corporation (the U.S.), NDD Medical Technologies, Inc. (the U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (the U.S.), Vitalograph (the U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (the U.S.), Midmark Corporation (the U.S.), Smiths Medical Inc. (the U.S.), and Koninklijke Philips N.V. (The Netherlands).
For more information visit at MarketResearchFuture
